Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2

Journal of Biological Chemistry

Volumn 287, Issue 28, 2012, Pages 23407-23417

  Deiss, Katharina ^a   Kisker, Caroline ^c   Lohse, Martin J ^a,b,c   Lorenz, Kristina ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR NETWORK; CO-IMMUNOPRECIPITATIONS; DIMER FORMATION; DIRECT INTERACTIONS; G PROTEIN-COUPLED RECEPTOR KINASE; KINASE INHIBITORS; PROTEIN-PROTEIN INTERACTIONS; PURIFIED PROTEIN; SIGNALING FUNCTIONS;

AMINO ACIDS; ENZYMES; PHOSPHORYLATION; PROTEINS;

DIMERIZATION;

DIMER; G PROTEIN COUPLED RECEPTOR KINASE 2; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RAF PROTEIN; RAF1 PROTEIN; SERINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; CROSS LINKING; DIMERIZATION; HEART; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BINDING, COMPETITIVE; CELL LINE; G-PROTEIN-COUPLED RECEPTOR KINASE 2; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; MUTANT PROTEINS; MUTATION; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-RAF; RATS; SERINE; SPODOPTERA;

MURINAE;

EID: 84863609981     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.363812     Document Type: Article

References (53)

1. Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K. D., Rose, D. W., Mischak, H., Sedivy, J. M., and Kolch, W. (1999) Suppression of Raf-1 kinase activity and MAP kinase signaling by RKIP. Nature 401, 173-177 (Pubitemid 29436321)
2. Yeung, K. C., Rose, D. W., Dhillon, A. S., Yaros, D., Gustafsson, M., Chatterjee, D., McFerran, B., Wyche, J., Kolch, W., and Sedivy, J. M. (2001) Raf kinase inhibitor protein interacts with NF-κB-inducing kinase and TAK1 and inhibits NF-κB activation. Mol. Cell Biol. 21, 7207-7217 (Pubitemid 32953475)
3. Al-Mulla, F., Bitar, M. S., Al-Maghrebi, M., Behbehani, A. I., Al-Ali, W., Rath, O., Doyle, B., Tan, K. Y., Pitt, A., and Kolch, W. (2011) Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β. Cancer Res. 71, 1334-1343
4. Lorenz, K., Lohse, M. J., and Quitterer, U. (2003) Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426, 574-579 (Pubitemid 37522645)
5. Kroslak, T. (2001) Human phosphatidylethanolamine-binding protein facilitates heterotrimericGprotein-dependent signaling. J. Biol. Chem. 276, 39772-39778
6. Bernier, I., Tresca, J. P., and Jollès, P. (1986) Ligand-binding studies with a 23-kDa protein purified from bovine brain cytosol. Biochim. Biophys. Acta 871, 19-23 (Pubitemid 16064521)
7. Vallée, B. S., Tauc, P., Brochon, J. C., Maget-Dana, R., Lelièvre, D., Metz-Boutigue, M. H., Bureaud, N., and Schoentgen, F. (2001) Behavior of bovine phosphatidylethanolamine-binding protein with model membranes. Evidence of affinity for negatively charged membranes. Eur. J. Biochem. 268, 5831-5841 (Pubitemid 33079318)
8. Banfield, M. J., Barker, J. J., Perry, A. C., and Brady, R. L. (1998) Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure 6, 1245-1254 (Pubitemid 28485957)
9. Zeng, L., Imamoto, A., and Rosner, M. R. (2008) Raf kinase inhibitory protein (RKIP). A physiological regulator and future therapeutic target. Expert Opin. Ther. Targets 12, 1275-1287
10. Kolch, W. (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6, 827-837
11. Keller, E. T., Fu, Z., and Brennan, M. (2004) The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem. Pharmacol. 68, 1049-1053 (Pubitemid 39094269)
12. Granovsky, A. E., and Rosner, M. R. (2008) Raf kinase inhibitory protein.A signal transduction modulator and metastasis suppressor. Cell Res. 18, 452-457 (Pubitemid 351498852)
13. Serre, L., Pereira de Jesus, K., Zelwer, C., Bureaud, N., Schoentgen, F., and Bénédetti, H. (2001) Crystal structures of YBHB and YBCL from Escherichia coli, two bacterial homologues to a Raf kinase inhibitor protein. J. Mol. Biol. 310, 617-634 (Pubitemid 32692574)
14. Granovsky, A. E., Clark, M. C., McElheny, D., Heil, G., Hong, J., Liu, X., Kim, Y., Joachimiak, G., Joachimiak, A., Koide, S., and Rosner, M. R. (2009) Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism. Mol. Cell Biol. 29, 1306-1320
15. Serre, L., Vallée, B., Bureaud, N., Schoentgen, F., and Zelwer, C. (1998) Crystal structure of the phosphatidylethanolamine-binding protein from bovine brain. A novel structural class of phospholipid-binding proteins. Structure 6, 1255-1265 (Pubitemid 28485958)
16. Shemon, A. N., Heil, G. L., Granovsky, A. E., Clark, M. M., McElheny, D., Chimon, A., Rosner, M. R., and Koide, S. (2010) Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket. NMR-based screening identifies small-molecule ligands. PLoS ONE 5, e10479
17. Rath, O., Park, S., Tang, H. H., Banfield, M. J., Brady, R. L., Lee, Y. C., Dignam, J. D., Sedivy, J. M., Kolch, W., and Yeung, K. C. (2008) The RKIP (Raf-1 kinase inhibitor protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK. Cell Signal 20, 935-941
18. Yeung, K., Janosch, P., McFerran, B., Rose, D. W., Mischak, H., Sedivy, J. M., and Kolch, W. (2000) Mechanism of suppression of the Raf/MEK/ extracellular signal-regulated kinase pathway by the Raf kinase inhibitor protein. Mol. Cell. Biol. 20, 3079-3085 (Pubitemid 30215020)
19. Banfield, M. J., and Brady, R. L. (2000) The structure of Antirrhinum centroradialis protein (CEN) suggests a role as a kinase regulator. J. Mol. Biol. 297, 1159-1170
20. Thal, D. M., Yeow, R. Y., Schoenau, C., Huber, J., and Tesmer, J. J. (2011) Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors. Mol. Pharmacol. 80, 294-303
21. Lorenz, K., Schmitt, J. P., Vidal, M., and Lohse, M. J. (2009) Cardiac hypertrophy. Targeting Raf/MEK/ERK1/2 signaling. Int. J. Biochem. Cell Biol. 41, 2351-2355
22. Maurer, G., Tarkowski, B., and Baccarini, M. (2011) Raf kinases in cancer roles and therapeutic opportunities. Oncogene 30, 3477-3488
23. Keller, E. T., Fu, Z., Yeung, K., and Brennan, M. (2004) Raf kinase inhibitor protein. A prostate cancer metastasis suppressor gene. Cancer Lett. 207, 131-137 (Pubitemid 38457033)
24. Pierce, K. L., Premont, R. T., and Lefkowitz, R. J. (2002) Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650 (Pubitemid 34987785)
25. Ribas, C., Penela, P., Murga, C., Salcedo, A., García-Hoz, C., Jurado-Pueyo, M., Aymerich, I., and Mayor, F. (2007) The G protein-coupled receptor kinase (GRK) interactome. Role of GRKs in GPCR regulation and signaling. Biochim. Biophys. Acta 1768, 913-922 (Pubitemid 46452540)
26. Gurevich, E. V., Tesmer, J. J., Mushegian, A., and Gurevich, V. V. (2012) G protein-coupled receptor kinases. More than just kinases and not only for GPCRs. Pharmacol. Ther. 133, 40-69
27. Rengo, G., Lymperopoulos, A., Leosco, D., and Koch, W. J. (2011) GRK2 as a novel gene therapy target in heart failure. J. Mol. Cell Cardiol. 50, 785-792
28. Corbit, K. C., Trakul, N., Eves, E. M., Diaz, B., Marshall, M., and Rosner, M. R. (2003) Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J. Biol. Chem. 278, 13061-13068 (Pubitemid 36800074)
29. Eichmann, T., Lorenz, K., Hoffmann, M., Brockmann, J., Krasel, C., Lohse, M. J., and Quitterer, U. (2003) The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gβγ binding site. J. Biol. Chem. 278, 8052-8057 (Pubitemid 36800544)
30. Dayhoff, J. E., Shoemaker, B. A., Bryant, S. H., and Panchenko, A. R. (2010) Evolution of protein binding modes in homo-oligomers. J. Mol. Biol. 395, 860-870
31. Cohen, C., and Parry, D. A. (1986) α-helical coiled coils - a widespread motif in proteins. Trends Biochem. Sci. 11, 245-248
32. Eves, E. M., Shapiro, P., Naik, K., Klein, U. R., Trakul, N., and Rosner, M. R. (2006) Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol. Cell 23, 561-574 (Pubitemid 44205493)
33. Keller, E. T., Fu, Z., and Brennan, M. (2005) The biology of a prostate cancer metastasis suppressor protein. Raf kinase inhibitor protein. J. Cell Biochem. 94, 273-278 (Pubitemid 41420306)
34. Al-Mulla, F., Bitar, M. S., Feng, J., Park, S., and Yeung, K. C. (2012) A new model for Raf kinase inhibitory protein induced chemotherapeutic resistance. PLoS One 7, e29532
35. Huang, J., Mahavadi, S., Sriwai, W., Grider, J. R., and Murthy, K. S. (2007) Cross-regulation of VPAC2 receptor desensitization by M3 receptors via PKC-mediated phosphorylation of RKIP and inhibition of GRK2. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G867-874 (Pubitemid 46442639)
36. Hellmann, J., Rommelspacher, H., Mühlbauer, E., and Wernicke, C. (2010) Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells. Dev. Neurosci. 32, 33-46
37. Hashimoto, K., and Panchenko, A. R. (2010) Mechanisms of protein oligomerization, the critical role of insertions and deletions in maintaining different oligomeric states. Proc. Natl. Acad. Sci. U.S.A. 107, 20352-20357
38. Nishi, H., Hashimoto, K., and Panchenko, A. R. (2011) Phosphorylation in protein-protein binding. Effect on stability and function. Structure 19, 1807-1815
39. Marianayagam, N. J., Sunde, M., and Matthews, J. M. (2004) The power of two. Protein dimerization in biology. Trends Biochem. Sci. 29, 618-625 (Pubitemid 39389082)
40. Nooren, I. M., and Thornton, J. M. (2003) Structural characterization and functional significance of transient protein-protein interactions. J. Mol. Biol. 325, 991-1018 (Pubitemid 36263408)
41. Khokhlatchev, A. V., Canagarajah, B., Wilsbacher, J., Robinson, M., Atkinson, M., Goldsmith, E., and Cobb, M. H. (1998) Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93, 605-615 (Pubitemid 28240721)
42. Lorenz, K., Schmitt, J. P., Schmitteckert, E. M., and Lohse, M. J. (2009) A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat. Med. 15, 75-83
43. Anderson, E., Quartararo, C., Brown, R. S., Shi, Y., Yao, X., and Cole, J. L. (2010) Analysis of monomeric and dimeric phosphorylated forms of protein kinase R. Biochemistry 49, 1217-1225
44. Bollengier, F., Beeckmans, S., Mahler, A., and Kanarek, L. (1989) Further physicochemical characterization of the novel human brain protein h3. J. Neurochem. 52, 1123-1126 (Pubitemid 19085935)
45. Akiva, E., Itzhaki, Z., and Margalit, H. (2008) Built-in loops allow versatility in domain-domain interactions. Lessons from self-interacting domains. Proc. Natl. Acad. Sci. U.S.A. 105, 13292-13297
46. Crasto, C. J., and Feng, J. (2001) Sequence codes for extended conformation. A neighbor-dependent sequence analysis of loops in proteins. Proteins 42, 399-413 (Pubitemid 32107764)
47. Jones, S., and Thornton, J. M. (1995) Protein-protein interactions. A review of protein dimer structures. Prog. Biophys. Mol. Biol. 63, 31-65
48. Ahn, J. H., Miller, D., Winter, V. J., Banfield, M. J., Lee, J. H., Yoo, S. Y., Henz, S. R., Brady, R. L., and Weigel, D. (2006) A divergent external loop confers antagonistic activity on floral regulators FT and TFL1. EMBO J. 25, 605-614 (Pubitemid 43237667)
49. 1-adrenergic receptors in the failing human heart. Circulation 87, 454-463
50. Lohse, M. J., Engelhardt, S., and Eschenhagen, T. (2003) What is the role of β-adrenergic signaling in heart failure? Circ. Res. 93, 896-906 (Pubitemid 37433227)
51. Belmonte, S. L., and Blaxall, B. C. (2011) G protein-coupled receptor kinases as therapeutic targets in cardiovascular disease. Circ. Res. 109, 309-319
52. Raake, P. W., Vinge, L. E., Gao, E., Boucher, M., Rengo, G., Chen, X., DeGeorge, B. R., Jr., Matkovich, S., Houser, S. R., Most, P., Eckhart, A. D., Dorn, G. W., 2nd, and Koch, W. J. (2008) G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ. Res. 103, 413-422
53. Koch, W. J., Rockman, H. A., Samama, P., Hamilton, R. A., Bond, R. A., Milano, C. A., and Lefkowitz, R. J. (1995) Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a β ARK inhibitor. Science 268, 1350-1353